Walleye Capital LLC Sarepta Therapeutics, Inc. Transaction History

Walleye Capital LLC

$38.9 Billion
Q4 2024

A detailed history of Walleye Capital LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 10,900 shares of SRPT stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,900

Previous 16,500 33.94%

Holding current value

$1.16 Million

Previous $2.06 Million 35.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$104.54 - $137.94 $570,056 - $752,186	-5,453 Reduced 55.16%	4,432 $538,000
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $3.2 Million - $4.04 Million	-25,777 Reduced 72.28%	9,885 $1.23 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $489,245 - $707,340	-4,317 Reduced 10.8%	35,662 $5.63 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $6.45 Million - $9.75 Million	-68,862 Reduced 63.27%	39,979 $5.18 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $4.51 Million - $8.37 Million	67,073 Added 160.58%	108,841 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $3.18 Million - $3.84 Million	31,032 Added 289.05%	41,768 $5.06 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $1.02 Million - $1.51 Million	-9,593 Reduced 47.19%	10,736 $1.23 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $3.21 Million - $4.26 Million	-27,340 Reduced 57.35%	20,329 $2.8 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $4.81 Million - $6.3 Million	47,669 New	47,669 $6.18 Million
Q2 2022 Aug 08, 2022	SELL	$62.69 - $88.44 $3.35 Million - $4.72 Million	-53,361 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $1.99 Million - $2.85 Million	31,488 Added 143.96%	53,361 $4.17 Million
Q4 2021 Mar 03, 2022	BUY	$77.28 - $99.42 $1.36 Million - $1.75 Million	17,626 Added 415.02%	21,873 $1.97 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $280,174 - $392,762	4,247 New	4,247 $393,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $782,745 - $978,713	-11,282 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $12,354 - $28,890	171 Added 1.54%	11,282 $841,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1.25 Million - $1.69 Million	11,111 New	11,111 $1.69 Million

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.35B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Sarepta Therapeutics, Inc. Transaction History